Ann Marie Navar, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005

Publications

Goldstein, BA, Navar, AM, and Carter, RE. "Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges." European heart journal 38, no. 23 (June 2017): 1805-1814.

PMID
27436868
Full Text

Pencina, M, Navar, AM, Wojdyla, D, Peterson, ED, and Gee, D. "LEVERAGING OPEN DATA TO CREATE NEW INSIGHTS IN CARDIOVASCULAR EPIDEMIOLOGY." May 2017.

Scholars@Duke

Lee, JC, Zdrojewski, T, and Navar, AM. "Statin Eligibility Under American and European Cholesterol Guidelines-Reply." JAMA cardiology 2, no. 4 (April 2017): 460-.

PMID
28097333
Full Text

Navar, AM, and Peterson, E. "The Complexities of Hypertension: One Disease or Many?." JAMA cardiology 2, no. 4 (April 2017): 389-390.

PMID
28199465
Full Text

Pagidipati, NJ, Navar, AM, Mulder, H, Sniderman, AD, Peterson, ED, and Pencina, MJ. "Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines." JAMA 317, no. 15 (April 2017): 1563-1567.

PMID
28418481
Full Text

Wang, T, Li, S, Navar, AM, Roger, V, Robinson, J, Goldberg, A, Virani, S, Elassal, J, Lee, LV, Wilson, P, and Peterson, E. "CONTEMPORARY PATTERNS OF LIPID TESTING IN PRIMARY AND SECONDARY PREVENTION PATIENTS: INSIGHTS FROM THE PALM REGISTRY." March 21, 2017.

Scholars@Duke

Hess, P, Kennedy, K, Cowherd, M, Virani, S, Masoudi, F, Navar, AM, Yeh, R, and Maddox, T. "IMPLICATIONS OF THE FDA APPROVAL OF PCSK9 INHIBITORS FOR CONTEMPORARY CARDIOVASCULAR PRACTICE: FINDINGS FROM THE NCDR (R) RESEARCH TO PRACTICE (R2P) PROJECT." March 21, 2017.

Scholars@Duke

Navar, AM, Steen, D, Wojdyla, D, Sanchez, R, Khan, I, Peterson, E, and Pencina, M. "RECURRENT CARDIOVASCULAR EVENT RATES IN A CONTEMPORARY COHORT OF 829,498 ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE." March 21, 2017.

Scholars@Duke

Goldstein, BA, Navar, AM, Pencina, MJ, and Ioannidis, JPA. "Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review." Journal of the American Medical Informatics Association : JAMIA 24, no. 1 (January 2017): 198-208. (Review)

PMID
27189013
Full Text

Navar, AM, Peterson, ED, and Wojdyla, D. "Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence (vol 316, pg 2041, 2016)." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 316, no. 22 (December 13, 2016): 2433-2433.

Scholars@Duke

Pages